![](/wp-content/uploads/2019/06/european-medicines-agency-announcement.png)
$599
High-dose Trulicity, DAPA-HF and Gvoke up for Opinions; CHMP Agenda September 14-17
The CHMP agenda for this month (September 14-17) has been released, and it includes three notable items: high-dose Trulicity, Dapa-HF, Xeris’s Gvoke, as well as several other agenda items. Below, FENIX provides diabetes-related highlights and insights from the September 2020 CHMP agenda.